Crossref
Safety Concerns Put a Stop to Maternal RSV Vaccine Study
JAMA · 2024
DOI: 10.1001/jama.2024.5155 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Early Termination of Clinical Trials, Premature Birth, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Early Termination of Clinical TrialsPremature BirthRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesFemaleHumansInfant, NewbornPregnancyPatient SafetyPregnancy Complications, InfectiousUnited States
Substanzen
Respiratory Syncytial Virus Vaccines
Zitieren
APA
Harris, E. (2024). Safety Concerns Put a Stop to Maternal RSV Vaccine Study. JAMA. https://doi.org/10.1001/jama.2024.5155
Vancouver
Harris E. Safety Concerns Put a Stop to Maternal RSV Vaccine Study. JAMA. 2024. doi:10.1001/jama.2024.5155
BibTeX
@article{Harris2024,
author = {Harris, Emily},
title = {Safety Concerns Put a Stop to Maternal RSV Vaccine Study},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.5155}
}
EUVIMED